Skip to content
Screener

Gross Profit at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$800.7M+42.1%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$14.74M+49.4%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$334.51M+16.9%
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$10.7M+2,873%
Operating income-$140.4M-26.0%
Net income-$127.8M-32.1%
EPS (diluted)-$1.23-18.3%

Balance sheet

See full
Cash & equivalents$115.1M+20.1%
Total debt$47.9M-5.8%
Total equity$1.3B+2.1%
Total assets$1.4B+2.9%

Cash flow

See full
Operating cash flow-$124.7M-41.0%
CapEx$820.0K-33.8%
Free cash flow-$125.5M-40.0%

Valuation

See full
Market cap$8.9B+233%
Enterprise value$8.84B+231%
P/S492.8×-1,427×

Profitability

See full
Gross margin150%-15.6pp
Operating margin-3,020.3%-1,463pp
Net margin-2,747.2%-1,328pp
FCF margin-2,321.7%-1,122pp

Returns & leverage

See full
Return on equity-39.2%+14.5pp
Debt / equity0.0×
Current ratio18.6×-3.9×

Where this comes from

Calculated from Crinetics Pharmaceuticals’s reported figures.

The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026. Open the filing →

Filed
May 7, 2026, 4:21 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001658247-26-000040

FAQ

What is Crinetics Pharmaceuticals's gross profit?
Crinetics Pharmaceuticals (CRNX) reported gross profit of $10.53M in Q1 2026.
How has Crinetics Pharmaceuticals's gross profit changed year-over-year?
Crinetics Pharmaceuticals's gross profit increased by 2818.0% year-over-year, from $361K to $10.53M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Ask your AI about Crinetics Pharmaceuticals's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude